What changed in AYTU BIOPHARMA, INC's 2025 10-K compared to 2024?

Across the narrative sections we track, AYTU BIOPHARMA, INC (AYTU) added 0 paragraphs, removed 0, and edited 0 between the 2024 and 2025 10-K filings. The biggest movers are .

Where does this AYTU 10-K diff come from?

The source filings are AYTU BIOPHARMA, INC's official 2024 and 2025 Form 10-K annual reports from SEC EDGAR. 10q10k.net parses each filing, aligns paragraphs by section (Item 1, 1A, 1C, 2, 3, 7, 7A), and highlights every added, removed and edited sentence side-by-side.

AYTU BIOPHARMA, INCAYTU财报

Nasdaq · 医疗保健 · 药物制剂

深度分析

Aytu BioPharma, Inc. is a US-based specialty pharmaceutical company that develops and commercializes a portfolio of consumer healthcare products and prescription therapeutics. Its key offerings cover cold and allergy treatments, sexual health solutions, and therapies for rare pediatric conditions, serving patients and healthcare providers across the United States.

What changed in AYTU BIOPHARMA, INC's 10-K — 2024 vs 2025

No meaningful paragraph-level changes detected in the compared sections. Either the two filings are nearly identical or the sections did not parse.

Other AYTU 10-K year-over-year comparisons

AYTU 10-K 2023 vs 2024
AYTU 10-K 2022 vs 2023